Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer

Published:2022-11 Issue:7 Volume:23 Page:e489-e499
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Galli Giulia^ORCID,Corsetto Paola Antonia,Proto Claudia,Lo Russo Giuseppe,Ganzinelli Monica,Rulli Eliana,Legramandi Lorenzo,Morelli Daniele,Ferrara Roberto,Prelaj Arsela,Signorelli Diego,De Toma Alessandro,Brambilla Marta,Occhipinti Mario,Manglaviti Sara,Boeri Mattia,Martinetti Antonia,Vingiani Andrea,Colombo Mario Paolo,Rizzo Angela Maria,Torri Valter,de Braud Filippo,Sangaletti Sabina,Sica Antonio,Garassino Marina Chiara

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference40 articles.

1. 2nd ESMO consensus conference on lung cancer: non-small-cell lung cancer first-line/second and further lines in advanced disease;Besse;Ann Oncol,2014

2. Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out;Proto;Cancer Treat Rev,2019

3. Immune checkpoint blockade: a new era for non-small cell lung cancer;Califano;Curr Oncol Rep,2016

4. Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors;Nadal;Cancer Immunol Immunother,2019

5. Monitoring checkpoint inhibitors: predictive biomarkers in immunotherapy;Zhang;Front Med,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Levels of serum lipids predict responses to PD-L1 inhibitors as first-line treatment in small cell lung cancer: an observational study;International Journal of Clinical Pharmacy;2024-09-12

2. Levels of serum lipids predict responses to PD-L1 inhibitor as first-line treatment in small cell lung cancer: an observational study;2024-04-30

3. Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study;The Oncologist;2023-10-05

4. Biomarkers for Immunotherapy in Driver-Gene-Negative Advanced NSCLC;International Journal of Molecular Sciences;2023-09-25

5. Evaluation of Fatty Acid Distributions and Triacylglycerol Species in Sow Milk and Commercial Piglet Formulas: A Comparative Study Based on Fat Sources and Lactation Stages;Animals;2022-12-28